Pfizer set to start shipping Remicade biosimilar next month

(Reuters) - Pfizer Inc said on Monday it plans to begin shipping its biosimilar version of Johnson & Johnson's blockbuster rheumatoid arthritis drug Remicade in late November at a 15 percent discount to current wholesale prices.

Pfizer set to start shipping Remicade biosimilar next month
Read More


Bagikan Berita Ini